143 related articles for article (PubMed ID: 8597119)
1. Genetic susceptibility and carcinogen-DNA adduct formation in human urinary bladder carcinogenesis.
Kadlubar FF; Badawi AF
Toxicol Lett; 1995 Dec; 82-83():627-32. PubMed ID: 8597119
[TBL] [Abstract][Full Text] [Related]
2. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder.
Badawi AF; Hirvonen A; Bell DA; Lang NP; Kadlubar FF
Cancer Res; 1995 Nov; 55(22):5230-7. PubMed ID: 7585581
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.
Badawi AF; Stern SJ; Lang NP; Kadlubar FF
Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis.
Hein DW
Mutat Res; 2002 Sep; 506-507():65-77. PubMed ID: 12351146
[TBL] [Abstract][Full Text] [Related]
5. The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers.
Rothman N; Bhatnagar VK; Hayes RB; Zenser TV; Kashyap SK; Butler MA; Bell DA; Lakshmi V; Jaeger M; Kashyap R; Hirvonen A; Schulte PA; Dosemeci M; Hsu F; Parikh DJ; Davis BB; Talaska G
Proc Natl Acad Sci U S A; 1996 May; 93(10):5084-9. PubMed ID: 8643532
[TBL] [Abstract][Full Text] [Related]
6. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
[TBL] [Abstract][Full Text] [Related]
7. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation.
Culp SJ; Roberts DW; Talaska G; Lang NP; Fu PP; Lay JO; Teitel CH; Snawder JE; Von Tungeln LS; Kadlubar FF
Mutat Res; 1997 Aug; 378(1-2):97-112. PubMed ID: 9288889
[TBL] [Abstract][Full Text] [Related]
8. Role of N-acetyltransferase 2 acetylation polymorphism in 4, 4'-methylene bis (2-chloroaniline) biotransformation.
Hein DW; Zhang X; Doll MA
Toxicol Lett; 2018 Feb; 283():100-105. PubMed ID: 29180287
[TBL] [Abstract][Full Text] [Related]
9. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.
Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461
[TBL] [Abstract][Full Text] [Related]
10. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
[TBL] [Abstract][Full Text] [Related]
11. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population.
Hung RJ; Boffetta P; Brennan P; Malaveille C; Hautefeuille A; Donato F; Gelatti U; Spaliviero M; Placidi D; Carta A; Scotto di Carlo A; Porru S
Int J Cancer; 2004 Jul; 110(4):598-604. PubMed ID: 15122594
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue.
Bell DA; Badawi AF; Lang NP; Ilett KF; Kadlubar FF; Hirvonen A
Cancer Res; 1995 Nov; 55(22):5226-9. PubMed ID: 7585580
[TBL] [Abstract][Full Text] [Related]
13. Activation of 3-nitrobenzanthrone and its metabolites by human acetyltransferases, sulfotransferases and cytochrome P450 expressed in Chinese hamster V79 cells.
Arlt VM; Glatt H; Muckel E; Pabel U; Sorg BL; Seidel A; Frank H; Schmeiser HH; Phillips DH
Int J Cancer; 2003 Jul; 105(5):583-92. PubMed ID: 12740904
[TBL] [Abstract][Full Text] [Related]
14. Metabolic activation and DNA adduct detection of PhIP in dogs, rats, and humans in relation to urinary bladder and colon carcinogenesis.
Kadlubar F; Kaderlik RK; Mulder GJ; Lin D; Butler MA; Teitel CH; Minchin RF; Ilett KF; Friesen MD; Bartsch H
Princess Takamatsu Symp; 1995; 23():207-13. PubMed ID: 8844812
[TBL] [Abstract][Full Text] [Related]
15. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
[TBL] [Abstract][Full Text] [Related]
16. DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in colon, bladder, and kidney of congenic mice differing in Ah responsiveness and N-acetyltransferase genotype.
Nerurkar PV; Schut HA; Anderson LM; Riggs CW; Snyderwine EG; Thorgeirsson SS; Weber WW; Rice JM; Levy GN
Cancer Res; 1995 Jul; 55(14):3043-9. PubMed ID: 7606725
[TBL] [Abstract][Full Text] [Related]
17. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
18. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D
Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636
[TBL] [Abstract][Full Text] [Related]
19. N-Acetyltransferase and sulfotransferase activity in human prostate: potential for carcinogen activation.
Al-Buheissi SZ; Patel HR; Meinl W; Hewer A; Bryan RL; Glatt H; Miller RA; Phillips DH
Pharmacogenet Genomics; 2006 Jun; 16(6):391-9. PubMed ID: 16708048
[TBL] [Abstract][Full Text] [Related]
20. DNA adducts from a tumorigenic metabolite of benzo[a]pyrene block human RNA polymerase II elongation in a sequence- and stereochemistry-dependent manner.
Perlow RA; Kolbanovskii A; Hingerty BE; Geacintov NE; Broyde S; Scicchitano DA
J Mol Biol; 2002 Aug; 321(1):29-47. PubMed ID: 12139931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
